Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Philips incorporates Biodesix's Nodify Lung blood-based testing into its system » 09:07
06/30/22
06/30
09:07
06/30/22
09:07
PHG

Philips

$21.33 /

+0.035 (+0.16%)

, BDSX

Biodesix

$1.36 /

-0.02 (-1.45%)

Royal Philips (PHG)…

Royal Philips (PHG) announced it has teamed up with Biodesix (BDSX) to incorporate the results of Biodesix's Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data - along with the radiologic and patient history data currently used to determine treatment decisions - can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases, via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator. "By incorporating Biodesix's Nodify Lung testing, we take another step in leveraging integrated diagnostics from imaging, genomics, and now proteomic results from a simple blood draw to address key moments in the lung cancer patient journey, support care team decision-making, and help health systems learn from their practice patterns in a dashboard view," said Louis Culot, General Manager Oncology Informatics and Genomics at Philips. "We expect the inclusion of Biodesix's ground-breaking technology in Philips Lung Cancer Orchestrator to help drive more confident decisions for the care team, and ultimately benefit patients."

ShowHide Related Items >><<
PHG Philips
$21.33 /

+0.035 (+0.16%)

BDSX Biodesix
$1.36 /

-0.02 (-1.45%)

PHG Philips
$21.33 /

+0.035 (+0.16%)

06/29/22 Deutsche Bank
Philips price target lowered to EUR 25 from EUR 30 at Deutsche Bank
06/16/22 UBS
Philips downgraded to Sell from Neutral at UBS
05/25/22 JPMorgan
Philips price target lowered to EUR 21.30 from EUR 26.50 at JPMorgan
05/25/22 JPMorgan
Philips downgraded to Underweight from Neutral at JPMorgan
BDSX Biodesix
$1.36 /

-0.02 (-1.45%)

06/13/22 Canaccord
Biodesix's Medicare coverage a meaningful milestone, says Canaccord
05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
PHG Philips
$21.33 /

+0.035 (+0.16%)

BDSX Biodesix
$1.36 /

-0.02 (-1.45%)

PHG Philips
$21.33 /

+0.035 (+0.16%)

BDSX Biodesix
$1.36 /

-0.02 (-1.45%)

BDSX Biodesix
$1.36 /

-0.02 (-1.45%)

Over a week ago
Conference/Events
Jefferies to hold a conference » 04:55
06/22/22
06/22
04:55
06/22/22
04:55
ABST

Absolute Software

$8.16 /

+0.25 (+3.16%)

, BANR

Banner Corp.

$55.97 /

+1.93 (+3.57%)

, CDW

CDW

$159.89 /

+3.39 (+2.17%)

, DGII

Digi International

$23.26 /

+0.55 (+2.42%)

, SKIN

Beauty Health

$11.78 /

+0.52 (+4.62%)

, XPOF

Xponential Fitness

$12.85 /

-0.02 (-0.16%)

, ATRI

Atrion

$624.30 /

-7.32 (-1.16%)

, CCMP

CMC Materials

$174.42 /

+1.68 (+0.97%)

, DEN

Denbury

$67.13 /

+3.42 (+5.37%)

, LNDC

Landec

$10.11 /

+0.36 (+3.69%)

, SKLZ

Skillz

$1.39 /

+0.045 (+3.35%)

, TRNS

Transcat

$59.18 /

+0.24 (+0.41%)

, TCX

Tucows

$40.93 /

-0.96 (-2.29%)

, TBI

TrueBlue

$16.83 /

+0.585 (+3.60%)

, SCHL

Scholastic

$35.53 /

+0.04 (+0.11%)

, SBEV

Splash Beverage

$2.06 /

+0.24 (+13.19%)

, EBET

EBET

$2.62 /

-0.125 (-4.55%)

, BEST

Best Inc.

$1.22 /

+0.01 (+0.83%)

, BDSX

Biodesix

$1.33 /

-0.12 (-8.28%)

, CHKP

Check Point

$120.11 /

+0.71 (+0.59%)

, CHEK

Check-Cap

/

+

, EAR

Eargo

$1.03 /

-0.02 (-1.90%)

, LVLU

Lulu's Fashion Lounge

$12.27 /

-0.4 (-3.16%)

, LMND

Lemonade

$17.70 /

+0.215 (+1.23%)

Consumer Conference to be…

Consumer Conference to be held in Nantucket, MA on June 20-22.

ShowHide Related Items >><<
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TCX Tucows
$40.93 /

-0.96 (-2.29%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SCHL Scholastic
$35.53 /

+0.04 (+0.11%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

EAR Eargo
$1.03 /

-0.02 (-1.90%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CHEK Check-Cap
/

+

CDW CDW
$159.89 /

+3.39 (+2.17%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

05/11/22 BMO Capital
Absolute Software price target lowered to C$12 from C$14 at BMO Capital
05/11/22 Canaccord
Absolute Software price target lowered to $17 from $22 at Canaccord
02/09/22 BMO Capital
Absolute Software price target lowered to C$14 from C$18.50 at BMO Capital
02/09/22 TD Securities
TD Securities upgrades Absolute Software to Buy after 'another' beat and raise
BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

06/17/22 Stephens
Stephens upgrades Banner to Overweight as Street mismodels rate sensitivity
06/17/22 Stephens
Banner Corp. upgraded to Overweight from Equal Weight at Stephens
01/24/22 Raymond James
Banner Corp. price target raised to $72 from $68 at Raymond James
09/07/21 DA Davidson
Banner Corp. downgraded to Neutral from Buy at DA Davidson
CDW CDW
$159.89 /

+3.39 (+2.17%)

05/05/22 Evercore ISI
CDW removed from 'TAP Outperform' list at Evercore ISI
04/18/22 Evercore ISI
CDW added to 'TAP Outperform' list at Evercore ISI
04/14/22 Stifel
CDW upgraded to Buy at Stifel following recent pullback
04/14/22 Stifel
CDW upgraded to Buy from Hold at Stifel
DGII Digi International
$23.26 /

+0.55 (+2.42%)

06/01/22 Stephens
Digi International initiated with an Overweight at Stephens
02/03/22 Canaccord
Digi International price target raised to $30 from $28 at Canaccord
11/11/21 Roth Capital
Digi International price target raised to $33 from $28 at Roth Capital
11/11/21 Canaccord
Digi International price target raised to $28 from $25 at Canaccord
SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

05/11/22 Canaccord
Beauty Health price target lowered to $22 from $27 at Canaccord
05/11/22 DA Davidson
Beauty Health price target lowered to $24 from $35 at DA Davidson
05/11/22 Piper Sandler
Beauty Health price target lowered to $24 from $26 at Piper Sandler
04/28/22 Piper Sandler
Beauty Health price target lowered to $26 from $31 at Piper Sandler
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
03/14/22 Evercore ISI
Evercore ISI starts Xponential Fitness at Outperform with $34 price target
03/14/22 Evercore ISI
Xponential Fitness initiated with an Outperform at Evercore ISI
03/14/22 Baird
Xponential Fitness price target raised to $28 from $26 at Baird
ATRI Atrion
$624.30 /

-7.32 (-1.16%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

04/07/22 CL King
CMC Materials downgraded to Neutral from Buy at CL King
04/07/22 CL King
CMC Materials downgraded to Neutral from Buy at CL King
02/04/22 Mizuho
CMC Materials downgraded to Neutral from Buy at Mizuho
12/17/21 Citi
CMC Materials upgraded to Neutral after buyout at Citi
DEN Denbury
$67.13 /

+3.42 (+5.37%)

05/24/22 Citi
California Resources, Denbury may be takeout targets, says Citi
05/10/22 Citi
Denbury initiated with a Buy at Citi
05/05/22 Stifel
Denbury price target raised to $129 from $126 at Stifel
04/26/22 KeyBanc
KeyBanc says Axios report positive for Plug Power, other fuel cell names
LNDC Landec
$10.11 /

+0.36 (+3.69%)

04/06/22 Barrington
Landec downgraded to Market Perform from Outperform at Barrington
09/30/21 Barrington
Landec price target lowered to $12 from $14 at Barrington
SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

05/23/22 Citi
Skillz downgraded to Neutral from Buy at Citi
03/01/22 Citi
Skillz price target lowered to $5 from $9 at Citi
02/24/22 Stifel
Skillz price target lowered to $3.50 from $16 at Stifel
02/24/22 Wedbush
Skillz price target lowered to $7.50 from $25 at Wedbush
TRNS Transcat
$59.18 /

+0.24 (+0.41%)

06/02/22 H.C. Wainwright
Transcat price target lowered to $85 from $105 at H.C. Wainwright
05/26/22 Roth Capital
Transcat price target lowered to $80 from $97 at Roth Capital
05/25/22 Craig-Hallum
Transcat price target lowered to $81 from $94 at Craig-Hallum
02/03/22 Craig-Hallum
Pullback in Transcat shares creates buying opportunity, says Craig-Hallum
TCX Tucows
$40.93 /

-0.96 (-2.29%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

05/26/22 BMO Capital
TrueBlue downgraded to Market Perform from Outperform at BMO Capital
04/11/22 Sidoti
TrueBlue reinstated with a Buy at Sidoti
10/26/21 Baird
TrueBlue price target raised to $35 from $31 at Baird
SCHL Scholastic
$35.53 /

+0.04 (+0.11%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

04/25/22 EF Hutton
Splash Beverage initiated with a Buy at EF Hutton
EBET EBET
$2.62 /

-0.125 (-4.55%)

02/07/22 Needham
Needham starts Esports Technologies at Buy on esports betting opportunity
02/07/22 Needham
Esports Technologies initiated with a Buy at Needham
BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

06/13/22 Canaccord
Biodesix's Medicare coverage a meaningful milestone, says Canaccord
05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
CHKP Check Point
$120.11 /

+0.71 (+0.59%)

05/23/22 Jefferies
Check Point price target lowered to $130 from $145 at Jefferies
04/28/22 Barclays
Check Point price target lowered to $145 from $160 at Barclays
04/28/22 Credit Suisse
Check Point price target raised to $115 from $105 at Credit Suisse
04/28/22 Wells Fargo
Check Point price target lowered to $130 from $144 at Wells Fargo
CHEK Check-Cap
/

+

02/07/22
Check-Cap upgraded to Buy from Neutral at Dawson James
EAR Eargo
$1.03 /

-0.02 (-1.90%)

09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 William Blair
William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
09/23/21 Wells Fargo
Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
09/23/21 William Blair
Eargo downgraded to Market Perform from Outperform at William Blair
LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

06/10/22 BofA
Lulu's Fashion Lounge downgraded to Neutral from Buy at BofA
01/14/22 Jefferies
Jefferies still believes in strength of Lulu's model after management meetings
12/06/21 Cowen
Cowen starts Lulu's Fashion Lounge with Outperform, affordable luxury brand
12/06/21 Baird
Baird starts Lulu's Fashion Lounge with Outperform, sees attractive value
LMND Lemonade
$17.70 /

+0.215 (+1.23%)

05/11/22 Oppenheimer
Lemonade price target lowered to $30 from $45 at Oppenheimer
05/11/22 JMP Securities
Lemonade price target lowered to $40 from $95 at JMP Securities
02/25/22 Barclays
Lemonade price target lowered to $22 from $43 at Barclays
02/25/22 Oppenheimer
Lemonade price target lowered to $45 from $85 at Oppenheimer
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

DGII Digi International
$23.26 /

+0.55 (+2.42%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CHEK Check-Cap
/

+

CDW CDW
$159.89 /

+3.39 (+2.17%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

  • 07
    Apr
  • 15
    Feb
  • 11
    Nov
  • 23
    Jul
LMND Lemonade
$17.70 /

+0.215 (+1.23%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CDW CDW
$159.89 /

+3.39 (+2.17%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

EAR Eargo
$1.03 /

-0.02 (-1.90%)

BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

Conference/Events
Jefferies to hold a conference » 00:03
06/22/22
06/22
00:03
06/22/22
00:03
ABST

Absolute Software

$8.16 /

+0.25 (+3.16%)

, BANR

Banner Corp.

$55.97 /

+1.93 (+3.57%)

, CDW

CDW

$159.89 /

+3.39 (+2.17%)

, DGII

Digi International

$23.26 /

+0.55 (+2.42%)

, SKIN

Beauty Health

$11.78 /

+0.52 (+4.62%)

, XPOF

Xponential Fitness

$12.85 /

-0.02 (-0.16%)

, ATRI

Atrion

$624.30 /

-7.32 (-1.16%)

, CCMP

CMC Materials

$174.42 /

+1.68 (+0.97%)

, DEN

Denbury

$67.13 /

+3.42 (+5.37%)

, LNDC

Landec

$10.11 /

+0.36 (+3.69%)

, SKLZ

Skillz

$1.39 /

+0.045 (+3.35%)

, TRNS

Transcat

$59.18 /

+0.24 (+0.41%)

, TCX

Tucows

$40.93 /

-0.96 (-2.29%)

, TBI

TrueBlue

$16.83 /

+0.585 (+3.60%)

, SCHL

Scholastic

$35.53 /

+0.04 (+0.11%)

, SBEV

Splash Beverage

$2.06 /

+0.24 (+13.19%)

, EBET

EBET

$2.62 /

-0.125 (-4.55%)

, BEST

Best Inc.

$1.22 /

+0.01 (+0.83%)

, BDSX

Biodesix

$1.33 /

-0.12 (-8.28%)

, CHKP

Check Point

$120.11 /

+0.71 (+0.59%)

, CHEK

Check-Cap

/

+

, EAR

Eargo

$1.03 /

-0.02 (-1.90%)

, LVLU

Lulu's Fashion Lounge

$12.27 /

-0.4 (-3.16%)

, LMND

Lemonade

$17.70 /

+0.215 (+1.23%)

Consumer Conference to be…

Consumer Conference to be held in Nantucket, MA on June 20-22.

ShowHide Related Items >><<
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TCX Tucows
$40.93 /

-0.96 (-2.29%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SCHL Scholastic
$35.53 /

+0.04 (+0.11%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

EAR Eargo
$1.03 /

-0.02 (-1.90%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CHEK Check-Cap
/

+

CDW CDW
$159.89 /

+3.39 (+2.17%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

05/11/22 BMO Capital
Absolute Software price target lowered to C$12 from C$14 at BMO Capital
05/11/22 Canaccord
Absolute Software price target lowered to $17 from $22 at Canaccord
02/09/22 BMO Capital
Absolute Software price target lowered to C$14 from C$18.50 at BMO Capital
02/09/22 TD Securities
TD Securities upgrades Absolute Software to Buy after 'another' beat and raise
BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

06/17/22 Stephens
Stephens upgrades Banner to Overweight as Street mismodels rate sensitivity
06/17/22 Stephens
Banner Corp. upgraded to Overweight from Equal Weight at Stephens
01/24/22 Raymond James
Banner Corp. price target raised to $72 from $68 at Raymond James
09/07/21 DA Davidson
Banner Corp. downgraded to Neutral from Buy at DA Davidson
CDW CDW
$159.89 /

+3.39 (+2.17%)

05/05/22 Evercore ISI
CDW removed from 'TAP Outperform' list at Evercore ISI
04/18/22 Evercore ISI
CDW added to 'TAP Outperform' list at Evercore ISI
04/14/22 Stifel
CDW upgraded to Buy at Stifel following recent pullback
04/14/22 Stifel
CDW upgraded to Buy from Hold at Stifel
DGII Digi International
$23.26 /

+0.55 (+2.42%)

06/01/22 Stephens
Digi International initiated with an Overweight at Stephens
02/03/22 Canaccord
Digi International price target raised to $30 from $28 at Canaccord
11/11/21 Roth Capital
Digi International price target raised to $33 from $28 at Roth Capital
11/11/21 Canaccord
Digi International price target raised to $28 from $25 at Canaccord
SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

05/11/22 Canaccord
Beauty Health price target lowered to $22 from $27 at Canaccord
05/11/22 DA Davidson
Beauty Health price target lowered to $24 from $35 at DA Davidson
05/11/22 Piper Sandler
Beauty Health price target lowered to $24 from $26 at Piper Sandler
04/28/22 Piper Sandler
Beauty Health price target lowered to $26 from $31 at Piper Sandler
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
03/14/22 Evercore ISI
Evercore ISI starts Xponential Fitness at Outperform with $34 price target
03/14/22 Evercore ISI
Xponential Fitness initiated with an Outperform at Evercore ISI
03/14/22 Baird
Xponential Fitness price target raised to $28 from $26 at Baird
ATRI Atrion
$624.30 /

-7.32 (-1.16%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

04/07/22 CL King
CMC Materials downgraded to Neutral from Buy at CL King
04/07/22 CL King
CMC Materials downgraded to Neutral from Buy at CL King
02/04/22 Mizuho
CMC Materials downgraded to Neutral from Buy at Mizuho
12/17/21 Citi
CMC Materials upgraded to Neutral after buyout at Citi
DEN Denbury
$67.13 /

+3.42 (+5.37%)

05/24/22 Citi
California Resources, Denbury may be takeout targets, says Citi
05/10/22 Citi
Denbury initiated with a Buy at Citi
05/05/22 Stifel
Denbury price target raised to $129 from $126 at Stifel
04/26/22 KeyBanc
KeyBanc says Axios report positive for Plug Power, other fuel cell names
LNDC Landec
$10.11 /

+0.36 (+3.69%)

04/06/22 Barrington
Landec downgraded to Market Perform from Outperform at Barrington
09/30/21 Barrington
Landec price target lowered to $12 from $14 at Barrington
SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

05/23/22 Citi
Skillz downgraded to Neutral from Buy at Citi
03/01/22 Citi
Skillz price target lowered to $5 from $9 at Citi
02/24/22 Stifel
Skillz price target lowered to $3.50 from $16 at Stifel
02/24/22 Wedbush
Skillz price target lowered to $7.50 from $25 at Wedbush
TRNS Transcat
$59.18 /

+0.24 (+0.41%)

06/02/22 H.C. Wainwright
Transcat price target lowered to $85 from $105 at H.C. Wainwright
05/26/22 Roth Capital
Transcat price target lowered to $80 from $97 at Roth Capital
05/25/22 Craig-Hallum
Transcat price target lowered to $81 from $94 at Craig-Hallum
02/03/22 Craig-Hallum
Pullback in Transcat shares creates buying opportunity, says Craig-Hallum
TCX Tucows
$40.93 /

-0.96 (-2.29%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

05/26/22 BMO Capital
TrueBlue downgraded to Market Perform from Outperform at BMO Capital
04/11/22 Sidoti
TrueBlue reinstated with a Buy at Sidoti
10/26/21 Baird
TrueBlue price target raised to $35 from $31 at Baird
SCHL Scholastic
$35.53 /

+0.04 (+0.11%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

04/25/22 EF Hutton
Splash Beverage initiated with a Buy at EF Hutton
EBET EBET
$2.62 /

-0.125 (-4.55%)

02/07/22 Needham
Needham starts Esports Technologies at Buy on esports betting opportunity
02/07/22 Needham
Esports Technologies initiated with a Buy at Needham
BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

06/13/22 Canaccord
Biodesix's Medicare coverage a meaningful milestone, says Canaccord
05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
CHKP Check Point
$120.11 /

+0.71 (+0.59%)

05/23/22 Jefferies
Check Point price target lowered to $130 from $145 at Jefferies
04/28/22 Barclays
Check Point price target lowered to $145 from $160 at Barclays
04/28/22 Credit Suisse
Check Point price target raised to $115 from $105 at Credit Suisse
04/28/22 Wells Fargo
Check Point price target lowered to $130 from $144 at Wells Fargo
CHEK Check-Cap
/

+

02/07/22
Check-Cap upgraded to Buy from Neutral at Dawson James
EAR Eargo
$1.03 /

-0.02 (-1.90%)

09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 William Blair
William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
09/23/21 Wells Fargo
Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
09/23/21 William Blair
Eargo downgraded to Market Perform from Outperform at William Blair
LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

06/10/22 BofA
Lulu's Fashion Lounge downgraded to Neutral from Buy at BofA
01/14/22 Jefferies
Jefferies still believes in strength of Lulu's model after management meetings
12/06/21 Cowen
Cowen starts Lulu's Fashion Lounge with Outperform, affordable luxury brand
12/06/21 Baird
Baird starts Lulu's Fashion Lounge with Outperform, sees attractive value
LMND Lemonade
$17.70 /

+0.215 (+1.23%)

05/11/22 Oppenheimer
Lemonade price target lowered to $30 from $45 at Oppenheimer
05/11/22 JMP Securities
Lemonade price target lowered to $40 from $95 at JMP Securities
02/25/22 Barclays
Lemonade price target lowered to $22 from $43 at Barclays
02/25/22 Oppenheimer
Lemonade price target lowered to $45 from $85 at Oppenheimer
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

DGII Digi International
$23.26 /

+0.55 (+2.42%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CHEK Check-Cap
/

+

CDW CDW
$159.89 /

+3.39 (+2.17%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

  • 07
    Apr
  • 15
    Feb
  • 11
    Nov
  • 23
    Jul
LMND Lemonade
$17.70 /

+0.215 (+1.23%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CDW CDW
$159.89 /

+3.39 (+2.17%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

EAR Eargo
$1.03 /

-0.02 (-1.90%)

BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

Recommendations
Biodesix's Medicare coverage a meaningful milestone, says Canaccord » 07:20
06/13/22
06/13
07:20
06/13/22
07:20
BDSX

Biodesix

$1.91 /

-0.14 (-6.83%)

Canaccord analyst Kyle…

Canaccord analyst Kyle Mikson noted Biodesix announced that WPS Government Health Administrators, the Medicare Administrative Contractor (MAC) with jurisdiction for BDSX's De Soto, Kansas, laboratory, had provided coverage for the Nodify CDT lung nodule test which is used by physicians to assess the risk of malignancy of a given lung nodule. The analyst believes broad coverage should drive adoption of the company's IQLung strategy for lung cancer patients and additionally, he believes that the new reimbursement could drive its margins higher over time. Mikson reiterated his Buy rating and $7 price target on Biodesix shares.

ShowHide Related Items >><<
BDSX Biodesix
$1.91 /

-0.14 (-6.83%)

BDSX Biodesix
$1.91 /

-0.14 (-6.83%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
BDSX Biodesix
$1.91 /

-0.14 (-6.83%)

BDSX Biodesix
$1.91 /

-0.14 (-6.83%)

BDSX Biodesix
$1.91 /

-0.14 (-6.83%)

Hot Stocks
Biodesix obtains Medicare coverage for Nodify CDT lung nodule test » 06:01
06/07/22
06/07
06:01
06/07/22
06:01
BDSX

Biodesix

$1.54 /

+0.085 (+5.84%)

Biodesix announced that…

Biodesix announced that WPS Government Health Administrators, the Medicare Administrative Contractor with jurisdiction for Biodesix's De Soto, Kansas laboratory, has provided coverage for the Nodify CDT lung nodule test. The Nodify CDT test is a part of the Biodesix's blood-based Nodify Lung Nodule Risk Assessment testing strategy consisting of two tests to aid physicians in stratifying patients into distinct nodule management treatment pathways: diagnostic procedure or imaging surveillance. The Nodify CDT test helps identify patients with lung nodules that are likely malignant or higher risk of cancer, and the Nodify XL2 test conversely helps identify those that are likely benign or lower risk of cancer.

ShowHide Related Items >><<
BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

Conference/Events
American Society of Clinical Oncology to hold annual meeting » 04:55
06/07/22
06/07
04:55
06/07/22
04:55
A

Agilent

$127.66 /

-0.79 (-0.62%)

, ALKS

Alkermes

$28.35 /

-0.935 (-3.19%)

, BDSX

Biodesix

$1.54 /

+0.085 (+5.84%)

, CSTL

Castle Biosciences

$21.53 /

+2.405 (+12.58%)

, ABBV

AbbVie

$146.65 /

-0.56 (-0.38%)

, ACET

Adicet Bio

$12.24 /

+0.74 (+6.43%)

, ACLX

Arcellx

$15.92 /

+3.295 (+26.10%)

, ADAP

Adaptimmune

$1.52 /

-0.145 (-8.73%)

, PFE

Pfizer

$53.23 /

+0.03 (+0.06%)

, PBYI

Puma Biotechnology

$2.39 /

+0.05 (+2.14%)

, ONCY

Oncolytics

$1.03 /

-0.075 (-6.79%)

, NVTA

Invitae

$2.93 /

-0.085 (-2.82%)

, NVS

Novartis

$88.68 /

-0.43 (-0.48%)

, NEO

NeoGenomics

$8.00 /

-0.075 (-0.93%)

, MTEM

Molecular Templates

/

+

, VBLT

VBL Therapeutics

$1.55 /

-0.07 (-4.32%)

, DSNKY

Daiichi Sankyo

$26.02 /

+1.02 (+4.08%)

, GLSI

Greenwich LifeSciences

$8.33 /

-0.675 (-7.50%)

, RTX

Raytheon Technologies

$97.25 /

+0.865 (+0.90%)

, SGEN

Seagen

$142.41 /

+2.5 (+1.79%)

, RHHBY

Roche

$41.23 /

-0.32 (-0.77%)

, EXEL

Exelixis

$18.80 /

-0.26 (-1.36%)

, FGEN

FibroGen

$9.52 /

-0.43 (-4.32%)

, CAH

Cardinal Health

$53.76 /

-0.075 (-0.14%)

, CBIO

Catalyst Biosciences

$1.15 /

-0.08 (-6.50%)

, ARVN

Arvinas

$42.76 /

-1.46 (-3.30%)

, AURA

Aura Biosciences

$17.44 /

-0.15 (-0.85%)

2022 ASCO Annual Meeting…

2022 ASCO Annual Meeting to be held in Chicago on June 3-7.

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.55 /

-0.07 (-4.32%)

SGEN Seagen
$142.41 /

+2.5 (+1.79%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

ONCY Oncolytics
$1.03 /

-0.075 (-6.79%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

MTEM Molecular Templates
/

+

GLSI Greenwich LifeSciences
$8.33 /

-0.675 (-7.50%)

FGEN FibroGen
$9.52 /

-0.43 (-4.32%)

EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

DSNKY Daiichi Sankyo
$26.02 /

+1.02 (+4.08%)

CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

AURA Aura Biosciences
$17.44 /

-0.15 (-0.85%)

ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

A Agilent
$127.66 /

-0.79 (-0.62%)

06/03/22 Cowen
Agilent premium valuation remains warranted, says Cowen
06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

04/28/22 Mizuho
Alkermes price target raised to $36 from $35 at Mizuho
04/28/22 H.C. Wainwright
Alkermes price target raised to $32 from $30 at H.C. Wainwright
04/27/22 Stifel
Alkermes price target raised to $27 from $24 at Stifel
04/20/22 Goldman Sachs
Alkermes initiated with a Buy at Goldman Sachs
BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

05/23/22 SVB Securities
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
03/08/22 Truist
Adicet Bio initiated with a Buy at Truist
03/04/22 Jefferies
Adicet Bio initiated with a Buy at Jefferies
ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

03/02/22 Barclays
Arcellx initiated with an Overweight at Barclays
03/01/22 SVB Securities
Arcellx initiated with an Outperform at SVB Leerink
03/01/22 BofA
Arcellx initiated with a Buy at BofA
03/01/22 BofA
Arcellx initiated with a Buy at BofA
ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

11/11/21 Roth Capital
Roth says Adaptimmune synovial sarcoma trial hitting goal appears 'a certainty'
PFE Pfizer
$53.23 /

+0.03 (+0.06%)

06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/31/22 Evercore ISI
Enanta upgraded to In Line from Underperform at Evercore ISI
05/25/22 Piper Sandler
Piper Sandler says Ventyx Biosciences' VTX002 could produce superior efficacy
05/23/22 Piper Sandler
Biohaven price target lowered to $149 from $170 at Piper Sandler
PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

05/06/22 H.C. Wainwright
Puma Biotechnology price target lowered to $12 from $14 at H.C. Wainwright
09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
ONCY Oncolytics
$1.03 /

-0.075 (-6.79%)

01/27/22 Canaccord
Oncolytics price target lowered to $6 from $7 at Canaccord
NVTA Invitae
$2.93 /

-0.085 (-2.82%)

06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
11/09/21 Wells Fargo
Invitae price target lowered to $25 from $35 at Wells Fargo
NVS Novartis
$88.68 /

-0.43 (-0.48%)

05/13/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/09/22 Wolfe Research
Novartis downgraded to Peer Perform from Outperform at Wolfe Research
NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

06/02/22 Piper Sandler
NeoGenomics initiated with an Overweight at Piper Sandler
03/29/22 Cowen
NeoGenomics price target lowered to $24 from $42 at Cowen
03/29/22 BTIG
NeoGenomics price target lowered to $28 from $35 at BTIG
03/29/22 SVB Securities
NeoGenomics price target lowered to $20 from $45 at SVB Leerink
MTEM Molecular Templates
/

+

05/27/22 BofA
Molecular Templates downgraded to Underperform from Buy at BofA
05/13/22 Stifel
Molecular Templates price target lowered to $9 from $11 at Stifel
03/30/22 Barclays
Molecular Templates price target lowered to $4.50 from $8 at Barclays
VBLT VBL Therapeutics
$1.55 /

-0.07 (-4.32%)

04/28/22 Chardan
VBL Therapeutics initiated with a Buy at Chardan
08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
DSNKY Daiichi Sankyo
$26.02 /

+1.02 (+4.08%)

10/27/21 SVB Securities
Seagen price target raised to $200 from $190 at SVB Leerink
GLSI Greenwich LifeSciences
$8.33 /

-0.675 (-7.50%)

09/01/21 H.C. Wainwright
Greenwich LifeSciences initiated with a Buy at H.C. Wainwright
RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
04/08/22 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
SGEN Seagen
$142.41 /

+2.5 (+1.79%)

04/08/22 Roth Capital
Bicycle reported 'very strong' side-effect profile, says Roth Capital
04/08/22 Cantor Fitzgerald
Bicycle Therapeutics' BT8009 abstract 'very positive,' says Cantor Fitzgerald
02/24/22 Piper Sandler
Seagen's tisotumab vedotin shows 'modest signal of activity,' says Piper Sandler
02/16/22 JMP Securities
Seagen price target lowered to $142 from $201 at JMP Securities
RHHBY Roche
$41.23 /

-0.32 (-0.77%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

05/19/22 Piper Sandler
Exelixis sold off on Cabometyx patent trial comments, says Piper Sandler
05/19/22 Truist
Exelixis should be bought on dip caused by '776 patent worries, says Truist
05/12/22 Jefferies
Exelixis could approach $26-$28 if it settles or wins MSN trial, says Jefferies
03/14/22 Piper Sandler
Exelixis price target lowered to $30 from $34 at Piper Sandler
FGEN FibroGen
$9.52 /

-0.43 (-4.32%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
FibroGen downgraded to Sell from Neutral at Goldman Sachs
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

05/26/22 Barclays
Cardinal Health downgraded to Equal Weight from Overweight at Barclays
05/18/22 Evercore ISI
Evercore upgrades Cardinal Health to Outperform on undervalued Medical segment
05/18/22 Evercore ISI
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
04/12/22 Morgan Stanley
McKesson price target raised to $370 from $292 at Morgan Stanley
CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

05/23/22 Piper Sandler
Arvinas price target lowered to $76 from $116 at Piper Sandler
05/09/22 Wedbush
Wedbush downgrades Arvinas to Neutral, cuts price target to $43
05/09/22 Wedbush
Arvinas downgraded to Neutral from Outperform at Wedbush
05/06/22 Cantor Fitzgerald
Arvinas assumed with an Overweight at Cantor Fitzgerald
AURA Aura Biosciences
$17.44 /

-0.15 (-0.85%)

11/23/21 SVB Securities
Aura Biosciences initiated with an Outperform at SVB Leerink
11/23/21 BTIG
Aura Biosciences initiated with a Buy at BTIG
11/23/21 Evercore ISI
Evercore starts Aura Biosciences at Outperform with $35 price target
11/23/21 Cowen
Aura Biosciences initiated with an Outperform at Cowen
VBLT VBL Therapeutics
$1.55 /

-0.07 (-4.32%)

SGEN Seagen
$142.41 /

+2.5 (+1.79%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

ONCY Oncolytics
$1.03 /

-0.075 (-6.79%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

MTEM Molecular Templates
/

+

FGEN FibroGen
$9.52 /

-0.43 (-4.32%)

EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

AURA Aura Biosciences
$17.44 /

-0.15 (-0.85%)

ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

  • 04
    Feb
  • 08
    Dec
  • 29
    Oct
RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

SGEN Seagen
$142.41 /

+2.5 (+1.79%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

Syndicate
Biodesix files to sell 2.88M shares of common stock for holders  17:26
06/06/22
06/06
17:26
06/06/22
17:26
BDSX

Biodesix

$1.54 /

+0.085 (+5.84%)

 
ShowHide Related Items >><<
BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

Conference/Events
American Society of Clinical Oncology to hold annual meeting » 10:01
06/06/22
06/06
10:01
06/06/22
10:01
A

Agilent

$129.14 /

+0.69 (+0.54%)

, ALKS

Alkermes

$29.06 /

-0.225 (-0.77%)

, BDSX

Biodesix

$1.45 /

-0.005 (-0.34%)

, CSTL

Castle Biosciences

$20.66 /

+1.535 (+8.03%)

, ABBV

AbbVie

$146.29 /

-0.92 (-0.62%)

, ACET

Adicet Bio

$11.21 /

-0.29 (-2.52%)

, ACLX

Arcellx

$13.44 /

+0.815 (+6.46%)

, ADAP

Adaptimmune

$1.63 /

-0.03 (-1.81%)

, PFE

Pfizer

$53.19 /

-0.01 (-0.02%)

, PBYI

Puma Biotechnology

$2.37 /

+0.025 (+1.07%)

, ONCY

Oncolytics

$1.08 /

-0.025 (-2.26%)

, NVTA

Invitae

$2.94 /

-0.075 (-2.49%)

, NVS

Novartis

$89.27 /

+0.16 (+0.18%)

, NEO

NeoGenomics

$8.11 /

+0.04 (+0.50%)

, MTEM

Molecular Templates

$1.03 /

+0.0523 (+5.35%)

, VBLT

VBL Therapeutics

$1.62 /

+ (+0.00%)

, DSNKY

Daiichi Sankyo

$25.00 /

-0.4 (-1.57%)

, GLSI

Greenwich LifeSciences

$8.89 /

-0.11 (-1.22%)

, RTX

Raytheon Technologies

$96.73 /

+0.345 (+0.36%)

, SGEN

Seagen

$143.37 /

+3.46 (+2.47%)

, RHHBY

Roche

$41.55 /

-0.7 (-1.66%)

, EXEL

Exelixis

$18.95 /

-0.105 (-0.55%)

, FGEN

FibroGen

$9.86 /

-0.09 (-0.90%)

, CAH

Cardinal Health

$53.94 /

+0.1 (+0.19%)

, CBIO

Catalyst Biosciences

$1.34 /

+0.11 (+8.94%)

, ARVN

Arvinas

$45.33 /

+1.11 (+2.51%)

, AURA

Aura Biosciences

$17.57 /

-0.02 (-0.11%)

2022 ASCO Annual Meeting…

2022 ASCO Annual Meeting to be held in Chicago on June 3-7.

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.62 /

+ (+0.00%)

SGEN Seagen
$143.37 /

+3.46 (+2.47%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

ONCY Oncolytics
$1.08 /

-0.025 (-2.26%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

MTEM Molecular Templates
$1.03 /

+0.0523 (+5.35%)

GLSI Greenwich LifeSciences
$8.89 /

-0.11 (-1.22%)

FGEN FibroGen
$9.86 /

-0.09 (-0.90%)

EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

DSNKY Daiichi Sankyo
$25.00 /

-0.4 (-1.57%)

CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

AURA Aura Biosciences
$17.57 /

-0.02 (-0.11%)

ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

A Agilent
$129.14 /

+0.69 (+0.54%)

06/03/22 Cowen
Agilent premium valuation remains warranted, says Cowen
06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

04/28/22 Mizuho
Alkermes price target raised to $36 from $35 at Mizuho
04/28/22 H.C. Wainwright
Alkermes price target raised to $32 from $30 at H.C. Wainwright
04/27/22 Stifel
Alkermes price target raised to $27 from $24 at Stifel
04/20/22 Goldman Sachs
Alkermes initiated with a Buy at Goldman Sachs
BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

05/23/22 SVB Securities
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
03/08/22 Truist
Adicet Bio initiated with a Buy at Truist
03/04/22 Jefferies
Adicet Bio initiated with a Buy at Jefferies
ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

03/02/22 Barclays
Arcellx initiated with an Overweight at Barclays
03/01/22 SVB Securities
Arcellx initiated with an Outperform at SVB Leerink
03/01/22 BofA
Arcellx initiated with a Buy at BofA
03/01/22 BofA
Arcellx initiated with a Buy at BofA
ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

11/11/21 Roth Capital
Roth says Adaptimmune synovial sarcoma trial hitting goal appears 'a certainty'
PFE Pfizer
$53.19 /

-0.01 (-0.02%)

06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/31/22 Evercore ISI
Enanta upgraded to In Line from Underperform at Evercore ISI
05/25/22 Piper Sandler
Piper Sandler says Ventyx Biosciences' VTX002 could produce superior efficacy
05/23/22 Piper Sandler
Biohaven price target lowered to $149 from $170 at Piper Sandler
PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

05/06/22 H.C. Wainwright
Puma Biotechnology price target lowered to $12 from $14 at H.C. Wainwright
09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
ONCY Oncolytics
$1.08 /

-0.025 (-2.26%)

01/27/22 Canaccord
Oncolytics price target lowered to $6 from $7 at Canaccord
NVTA Invitae
$2.94 /

-0.075 (-2.49%)

06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
11/09/21 Wells Fargo
Invitae price target lowered to $25 from $35 at Wells Fargo
NVS Novartis
$89.27 /

+0.16 (+0.18%)

05/13/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/09/22 Wolfe Research
Novartis downgraded to Peer Perform from Outperform at Wolfe Research
NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

06/02/22 Piper Sandler
NeoGenomics initiated with an Overweight at Piper Sandler
03/29/22 Cowen
NeoGenomics price target lowered to $24 from $42 at Cowen
03/29/22 BTIG
NeoGenomics price target lowered to $28 from $35 at BTIG
03/29/22 SVB Securities
NeoGenomics price target lowered to $20 from $45 at SVB Leerink
MTEM Molecular Templates
$1.03 /

+0.0523 (+5.35%)

05/27/22 BofA
Molecular Templates downgraded to Underperform from Buy at BofA
05/13/22 Stifel
Molecular Templates price target lowered to $9 from $11 at Stifel
03/30/22 Barclays
Molecular Templates price target lowered to $4.50 from $8 at Barclays
VBLT VBL Therapeutics
$1.62 /

+ (+0.00%)

04/28/22 Chardan
VBL Therapeutics initiated with a Buy at Chardan
08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
DSNKY Daiichi Sankyo
$25.00 /

-0.4 (-1.57%)

10/27/21 SVB Securities
Seagen price target raised to $200 from $190 at SVB Leerink
GLSI Greenwich LifeSciences
$8.89 /

-0.11 (-1.22%)

09/01/21 H.C. Wainwright
Greenwich LifeSciences initiated with a Buy at H.C. Wainwright
RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
04/08/22 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
SGEN Seagen
$143.37 /

+3.46 (+2.47%)

04/08/22 Roth Capital
Bicycle reported 'very strong' side-effect profile, says Roth Capital
04/08/22 Cantor Fitzgerald
Bicycle Therapeutics' BT8009 abstract 'very positive,' says Cantor Fitzgerald
02/24/22 Piper Sandler
Seagen's tisotumab vedotin shows 'modest signal of activity,' says Piper Sandler
02/16/22 JMP Securities
Seagen price target lowered to $142 from $201 at JMP Securities
RHHBY Roche
$41.55 /

-0.7 (-1.66%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

05/19/22 Piper Sandler
Exelixis sold off on Cabometyx patent trial comments, says Piper Sandler
05/19/22 Truist
Exelixis should be bought on dip caused by '776 patent worries, says Truist
05/12/22 Jefferies
Exelixis could approach $26-$28 if it settles or wins MSN trial, says Jefferies
03/14/22 Piper Sandler
Exelixis price target lowered to $30 from $34 at Piper Sandler
FGEN FibroGen
$9.86 /

-0.09 (-0.90%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
FibroGen downgraded to Sell from Neutral at Goldman Sachs
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

05/26/22 Barclays
Cardinal Health downgraded to Equal Weight from Overweight at Barclays
05/18/22 Evercore ISI
Evercore upgrades Cardinal Health to Outperform on undervalued Medical segment
05/18/22 Evercore ISI
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
04/12/22 Morgan Stanley
McKesson price target raised to $370 from $292 at Morgan Stanley
CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

05/23/22 Piper Sandler
Arvinas price target lowered to $76 from $116 at Piper Sandler
05/09/22 Wedbush
Wedbush downgrades Arvinas to Neutral, cuts price target to $43
05/09/22 Wedbush
Arvinas downgraded to Neutral from Outperform at Wedbush
05/06/22 Cantor Fitzgerald
Arvinas assumed with an Overweight at Cantor Fitzgerald
AURA Aura Biosciences
$17.57 /

-0.02 (-0.11%)

11/23/21 SVB Securities
Aura Biosciences initiated with an Outperform at SVB Leerink
11/23/21 BTIG
Aura Biosciences initiated with a Buy at BTIG
11/23/21 Evercore ISI
Evercore starts Aura Biosciences at Outperform with $35 price target
11/23/21 Cowen
Aura Biosciences initiated with an Outperform at Cowen
VBLT VBL Therapeutics
$1.62 /

+ (+0.00%)

SGEN Seagen
$143.37 /

+3.46 (+2.47%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

ONCY Oncolytics
$1.08 /

-0.025 (-2.26%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

MTEM Molecular Templates
$1.03 /

+0.0523 (+5.35%)

FGEN FibroGen
$9.86 /

-0.09 (-0.90%)

EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

AURA Aura Biosciences
$17.57 /

-0.02 (-0.11%)

ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

  • 04
    Feb
  • 08
    Dec
  • 29
    Oct
RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

SGEN Seagen
$143.37 /

+3.46 (+2.47%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

Hot Stocks
Biodesix announces research agreement with top U.S. cancer center » 06:01
06/03/22
06/03
06:01
06/03/22
06:01
BDSX

Biodesix

$1.43 /

+0.055 (+4.00%)

Biodesix announced that…

Biodesix announced that it intends to develop a new novel minimal residual disease test as a part of a master sponsored research agreement with Memorial Sloan Kettering Cancer Center. In addition, the MSRA between MSK and Biodesix also includes the potential future development of other diagnostic tests aimed at improving the treatment of cancer. Biodesix will utilize its array of genomics, proteomics, artificial intelligence, and machine learning capabilities with the aim of developing and commercializing oncology biomarker assays in collaboration with MSK. Initially, the teams will collaborate to develop a highly sensitive molecular MRD test on the new ddPCR platform, the Bio-Rad QX600 ddPCR System.

ShowHide Related Items >><<
BDSX Biodesix
$1.43 /

+0.055 (+4.00%)

BDSX Biodesix
$1.43 /

+0.055 (+4.00%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
BDSX Biodesix
$1.43 /

+0.055 (+4.00%)

BDSX Biodesix
$1.43 /

+0.055 (+4.00%)

BDSX Biodesix
$1.43 /

+0.055 (+4.00%)

Over a month ago
Recommendations
Biodesix price target lowered to $7 from $10 at Canaccord » 07:58
05/12/22
05/12
07:58
05/12/22
07:58
BDSX

Biodesix

$1.56 /

-0.265 (-14.52%)

Canaccord analyst Kyle…

Canaccord analyst Kyle Mikson lowered the firm's price target on Biodesix to $7 from $10 and keeps a Buy rating on the shares. The analyst said he believes the company's core business is rebounding nicely and Biodesix appears to be gradually executing on its growth strategy. He continues to believe the shares offer significant upside potential from current levels.

ShowHide Related Items >><<
BDSX Biodesix
$1.56 /

-0.265 (-14.52%)

BDSX Biodesix
$1.56 /

-0.265 (-14.52%)

04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
02/15/22 Canaccord
Biodesix price target lowered to $18 from $22 at Canaccord
BDSX Biodesix
$1.56 /

-0.265 (-14.52%)

BDSX Biodesix
$1.56 /

-0.265 (-14.52%)

BDSX Biodesix
$1.56 /

-0.265 (-14.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.